MARKET

FTSV

FTSV

Forty Seven
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.97
-0.29
-4.63%
After Hours: 5.97 0 0.00% 16:00 10/22 EDT
OPEN
6.28
PREV CLOSE
6.26
HIGH
6.60
LOW
5.92
VOLUME
121.57K
TURNOVER
--
52 WEEK HIGH
23.83
52 WEEK LOW
5.69
MARKET CAP
176.86M
P/E (TTM)
-1.9302
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FTSV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

FTSV News

  • These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year
  • American City Business Journals.4d ago
  • Stocks That Hit 52-Week Lows On Tuesday
  • Benzinga.10/08 16:02
  • Forty Seven Inc. to Present at 2019 Cantor Global Healthcare Conference
  • GlobeNewswire.09/27 13:01
  • Benzinga's Top Upgrades, Downgrades For September 12, 2019
  • Benzinga.09/12 13:32

More

Industry

Biotechnology & Medical Research
+0.44%
Pharmaceuticals & Medical Research
+0.60%

Hot Stocks

Name
Price
%Change

About FTSV

Forty Seven, Inc. is clinical-stage immuno-oncology company. The Company is focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer. The Company’s lead product candidate, 5F9, is a humanized IgG4 subclass monoclonal antibody against CD47 that is designed to interfere with recognition of CD47 by the SIRPa receptor on macrophages. The Company’s another product FSI-189, is an antibody that binds to SIRPa and initiate Phase I solid tumor trials for FSI-189. The Company is investigating 5F9 in multiple Phase I and Phase II trials in various cancers including acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL) and colorectal carcinoma (CRC), and ovarian cancer, as both a monotherapy and in combination with other therapies, such as rituximab and cetuximab. In addition to the 5F9, which is an antibody that binds to CD47 blocking its binding to SIRPa.
More

Webull offers Forty Seven Inc (FTSV) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.